Predilife Revenue and Competitors
Estimated Revenue & Valuation
- Predilife's estimated annual revenue is currently $10M per year.
- Predilife's estimated revenue per employee is $251,000
Employee Data
- Predilife has 40 Employees.
- Predilife grew their employee count by 3% last year.
Predilife's People
Name | Title | Email/Phone |
---|
Predilife Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Predilife?
Predilife is an innovative company specializing in statistics and data mining applied to predictive and preventive medicine. Predilife designed Mammorisk solution: - An expert software for calculating the breast cancer risk of your patient; streamlined and easy to use in your daily workflow - Results in graphic form that can easily be shared with the patient and prescribers. - Automatic creation of a personalized multi year, individualized screening plan - Adjustment of the frequency and imaging modalities (US, MRI..) of your patient's screening plan, based on her own breast cancer risk, from official recommendations. - Performs automatically a qualitative assessment of breast density, simulates the visual evaluation by the radiologist MammoRisk, designed in collaboration with the center Gustave Roussy (Paris, France), was the subject of a patent application regarding the methodology "Nearest Neighbours" applied to the prediction of diseases. Statlife, The sooner, the better
keywords:N/AN/A
Total Funding
40
Number of Employees
$10M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Predilife News
Villejuif, France, le 7 avril 2022, 7h - PREDILIFE (Euronext Growth : ALPRE FR0010169920), spécialiste de solutions innovantes de prédiction...
Predilife : NUOMA, LA MUTUELLE DE LA " HIGH TECH ", PREMIERE MUTUELLE A REMBOURSER LES BILANS DE PREDICTION DU CANCER DU SEIN. Lien copié. 07/04...